Live
- Over 7,600 Syrians return from Turkiye in five days after Assad's downfall: minister
- Delhi BJP leaders stay overnight in 1,194 slum clusters
- Keerthy Suresh and Anthony Thattil Tie the Knot in a Christian Ceremony
- AAP, BJP making false promises to slum dwellers for votes: Delhi Congress
- 'Vere Level Office' Review: A Refreshing Take on Corporate Life with Humor and Heart
- Libya's oil company declares force majeure at key refinery following clashes
- Illegal Rohingyas: BJP seeks Assembly session to implement NRC in Delhi
- Philippines orders full evacuation amid possible volcanic re-eruption
- Government Prioritizes Welfare of the Poor, says Dola Sri Bala Veeranjaneyaswamy
- Two Russian oil tankers with 29 on board damaged due to bad weather
Centre approves Corbevax as precaution dose
Centre approves Corbevax as precaution dose
Highlights
The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
New Delhi: The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines.
Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.
In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826.
Next Story
ADVERTISEMENT
